FRESENIUS MEDICAL CARE AG Profit Loss Attributable To Noncontrolling Interests
FRESENIUS MEDICAL CARE AG (FMS) reported Profit Loss Attributable To Noncontrolling Interests of EUR 212.90 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Notes
ifrs-full:ProfitLossAttributableToNoncontrollingInterests · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG profit loss attributable to noncontrolling interests for the quarter ending 2025-12-31 was 74.94M EUR, a 46.32% increase year-over-year.
- FRESENIUS MEDICAL CARE AG profit loss attributable to noncontrolling interests for the quarter ending 2025-09-30 was 52.55M EUR, a 3.10% increase year-over-year.
- FRESENIUS MEDICAL CARE AG profit loss attributable to noncontrolling interests for the quarter ending 2025-06-30 was 47.02M EUR, a 11.97% decline year-over-year.
- FRESENIUS MEDICAL CARE AG profit loss attributable to noncontrolling interests for the quarter ending 2025-03-31 was 38.39M EUR, a 18.94% decline year-over-year.
| Period end | Profit Loss Attributable To Noncontrolling Interests 3 month | Profit Loss Attributable To Noncontrolling Interests 6 month | Profit Loss Attributable To Noncontrolling Interests 9 month | Profit Loss Attributable To Noncontrolling Interests 12 month |
|---|---|---|---|---|
| 2025-12-31 | 74.94M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 127.49M EUR derived: sum of 2 quarters · filed 2026-02-24 | 174.51M EUR derived: sum of 3 quarters · filed 2026-02-24 | 212.90M EUR 20-F · filed 2026-02-24 |
| 2025-09-30 | 52.55M EUR 6-K · filed 2025-11-04 | 99.57M EUR derived: sum of 2 quarters · filed 2025-11-04 | 137.96M EUR 6-K · filed 2025-11-04 | 189.18M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2025-06-30 | 47.02M EUR 6-K · filed 2025-08-05 | 85.41M EUR 6-K · filed 2025-08-05 | 136.63M EUR derived: sum of 3 quarters · filed 2026-02-24 | 187.60M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2025-03-31 | 38.39M EUR 6-K · filed 2025-05-06 | 89.61M EUR derived: sum of 2 quarters · filed 2026-02-24 | 140.57M EUR derived: sum of 3 quarters · filed 2026-02-24 | 193.99M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-12-31 | 51.22M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 102.18M EUR derived: sum of 2 quarters · filed 2026-02-24 | 155.60M EUR derived: sum of 3 quarters · filed 2026-02-24 | 202.96M EUR 20-F · filed 2026-02-24 |
| 2024-09-30 | 50.97M EUR 6-K · filed 2025-11-04 | 104.38M EUR derived: sum of 2 quarters · filed 2025-11-04 | 151.74M EUR 6-K · filed 2025-11-04 | 220.41M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | 53.42M EUR 6-K · filed 2025-08-05 | 100.77M EUR 6-K · filed 2025-08-05 | 169.45M EUR derived: sum of 3 quarters · filed 2026-02-24 | 232.16M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | 47.36M EUR 6-K · filed 2025-05-06 | 116.03M EUR derived: sum of 2 quarters · filed 2026-02-24 | 178.74M EUR derived: sum of 3 quarters · filed 2026-02-24 | 233.33M EUR derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | 68.67M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 131.38M EUR derived: sum of 2 quarters · filed 2026-02-24 | 185.97M EUR derived: sum of 3 quarters · filed 2026-02-24 | 233.46M EUR 20-F · filed 2026-02-24 |
| 2023-09-30 | 62.71M EUR 6-K · filed 2024-11-05 | 117.30M EUR derived: sum of 2 quarters · filed 2024-11-05 | 164.79M EUR 6-K · filed 2024-11-05 | 219.57M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | 54.59M EUR 6-K · filed 2024-07-30 | 102.08M EUR 6-K · filed 2024-07-30 | 156.86M EUR derived: sum of 3 quarters · filed 2025-02-25 | 209.69M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | 47.49M EUR 6-K · filed 2024-05-07 | 102.27M EUR derived: sum of 2 quarters · filed 2025-02-25 | 155.10M EUR derived: sum of 3 quarters · filed 2025-02-25 | 213.97M EUR derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | 54.78M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-25 | 107.61M EUR derived: sum of 2 quarters · filed 2025-02-25 | 166.47M EUR derived: sum of 3 quarters · filed 2025-02-25 | 220.92M EUR 20-F · filed 2025-02-25 |
| 2022-09-30 | 52.83M EUR 6-K · filed 2023-11-02 | 111.70M EUR derived: sum of 2 quarters · filed 2023-11-02 | 166.14M EUR 6-K · filed 2023-11-02 | 241.14M EUR derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | 58.87M EUR 6-K · filed 2023-08-02 | 113.31M EUR 6-K · filed 2023-08-02 | 188.31M EUR derived: sum of 3 quarters · filed 2024-02-20 | 246.50M EUR derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | 54.45M EUR 6-K · filed 2023-05-09 | 129.44M EUR derived: sum of 2 quarters · filed 2024-02-20 | 187.64M EUR derived: sum of 3 quarters · filed 2024-02-20 | 248.78M EUR derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | 75.00M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-20 | 133.19M EUR derived: sum of 2 quarters · filed 2024-02-20 | 194.33M EUR derived: sum of 3 quarters · filed 2024-02-20 | 249.72M EUR 20-F · filed 2024-02-20 |
| 2021-09-30 | 58.19M EUR 6-K · filed 2022-10-31 | 119.33M EUR derived: sum of 2 quarters · filed 2022-10-31 | 174.72M EUR 6-K · filed 2022-10-31 | 236.34M EUR derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | 61.14M EUR 6-K · filed 2022-08-02 | 116.53M EUR 6-K · filed 2022-08-02 | 178.15M EUR derived: sum of 3 quarters · filed 2023-02-22 | 244.39M EUR derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | 55.39M EUR 6-K · filed 2022-05-04 | 117.00M EUR derived: sum of 2 quarters · filed 2023-02-22 | 183.25M EUR derived: sum of 3 quarters · filed 2023-02-22 | 259.19M EUR derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | 61.62M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-22 | 127.86M EUR derived: sum of 2 quarters · filed 2023-02-22 | 203.81M EUR derived: sum of 3 quarters · filed 2023-02-22 | 271.45M EUR 20-F · filed 2023-02-22 |
| 2020-09-30 | 66.24M EUR 6-K · filed 2021-11-02 | 142.19M EUR derived: sum of 2 quarters · filed 2021-11-02 | 209.84M EUR 6-K · filed 2021-11-02 | 271.88M EUR derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | 75.94M EUR 6-K · filed 2021-07-30 | 143.59M EUR 6-K · filed 2021-07-30 | 205.63M EUR derived: sum of 3 quarters · filed 2022-02-22 | 264.61M EUR derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | 67.65M EUR 6-K · filed 2021-05-06 | 129.69M EUR derived: sum of 2 quarters · filed 2022-02-22 | 188.66M EUR derived: sum of 3 quarters · filed 2022-02-22 | 249.52M EUR derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | 62.04M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-02-22 | 121.02M EUR derived: sum of 2 quarters · filed 2022-02-22 | 181.87M EUR derived: sum of 3 quarters · filed 2022-02-22 | 238.88M EUR 20-F · filed 2022-02-22 |
| 2019-09-30 | 58.98M EUR 6-K · filed 2020-10-29 | 119.83M EUR derived: sum of 2 quarters · filed 2020-10-29 | 176.84M EUR 6-K · filed 2020-10-29 | 244.30M EUR derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | 60.86M EUR 6-K · filed 2020-07-30 | 117.87M EUR 6-K · filed 2020-07-30 | 185.32M EUR derived: sum of 3 quarters · filed 2021-02-23 | 249.27M EUR derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | 57.01M EUR 6-K · filed 2020-05-06 | 124.46M EUR derived: sum of 2 quarters · filed 2021-02-23 | 188.41M EUR derived: sum of 3 quarters · filed 2021-02-23 | 249.59M EUR derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | 67.45M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-02-23 | 131.40M EUR derived: sum of 2 quarters · filed 2021-02-23 | 192.58M EUR derived: sum of 3 quarters · filed 2021-02-23 | 243.73M EUR 20-F · filed 2021-02-23 |
| 2018-09-30 | 63.95M EUR 6-K · filed 2019-10-31 | 125.13M EUR derived: sum of 2 quarters · filed 2019-10-31 | 176.28M EUR 6-K · filed 2019-10-31 | 251.43M EUR derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-06-30 | 61.18M EUR 6-K · filed 2019-07-30 | 112.33M EUR 6-K · filed 2019-07-30 | 187.48M EUR derived: sum of 3 quarters · filed 2020-02-20 | 249.14M EUR derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-03-31 | 51.15M EUR 6-K · filed 2019-05-02 | 126.30M EUR derived: sum of 2 quarters · filed 2020-02-20 | 187.96M EUR derived: sum of 3 quarters · filed 2020-02-20 | 257.09M EUR derived: sum of 4 quarters · filed 2020-02-20 |
| 2017-12-31 | 75.14M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-02-20 | 136.81M EUR derived: sum of 2 quarters · filed 2020-02-20 | 205.94M EUR derived: sum of 3 quarters · filed 2020-02-20 | 274.75M EUR 20-F · filed 2020-02-20 |
| 2017-09-30 | 61.66M EUR 6-K · filed 2018-10-30 | 130.79M EUR derived: sum of 2 quarters · filed 2018-10-30 | 199.60M EUR 6-K · filed 2018-10-30 | |
| 2017-06-30 | 69.13M EUR 6-K · filed 2018-08-01 | 137.94M EUR 6-K · filed 2018-08-01 | ||
| 2017-03-31 | 68.81M EUR 6-K · filed 2018-05-03 | |||
| 2016-12-31 | 276.07M EUR 20-F · filed 2019-02-20 | |||
| 2015-12-31 | 255.70M EUR 20-F · filed 2018-02-27 |